[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335812-105":59,"doc-detail-335812-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","engineering-and-targeting-potential-of-car-nk-cells-in-colorectal-cancer-review-article","Engineering and targeting potential of CAR NK cells in colorectal cancer - Review Article","","Colorectal cancer (CRC) presents an urgent global health challenge requiring advanced therapies. Chimeric antigen receptor (CAR) T cells show promise but face key limitations. CAR natural killer (NK) cells are highlighted as emerging alternatives with higher safety, cost-effectiveness, and solid-tumor efficacy. Further work is needed to clarify CAR NK trafficking mechanisms and interactions with the tumor microenvironment. This review covers CAR NK design and engineering, antigen targets in CRC, and strategies addressing resistance, emphasizing clinical trial potential.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/engineering-and-targeting-potential-of-car-nk-cells-in-colorectal-cancer-review-article/335812/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/engineering-and-targeting-potential-of-car-nk-cells-in-colorectal-cancer-review-article/335812.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are CAR NK cells considered for colorectal cancer treatment?","Question",{"text":113,"@type":114},"CAR NK cells are presented as alternatives to CAR T cells, offering advantages such as higher safety profiles, cost-effectiveness, and efficacy against solid tumors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What challenges limit CAR T cell therapies in CRC?",{"text":118,"@type":114},"The text notes demerits including limited T cell trafficking, immunosuppressive tumor environments, and antigen escape.",{"name":120,"@type":111,"acceptedAnswer":121},"What does the review focus on regarding CAR NK cells?",{"text":122,"@type":114},"It explains CAR NK cell design and engineering, identifies antigen targets in CRC, and discusses strategies to overcome resistance mechanisms with emphasis on preclinical progress and clinical trial potential.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335812,1790129215,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","| Review Article |\n| --- |\n| Engineering and targeting potential of CAR NK cells in colorectal cancer\u003Cbr>Muhammad Babar Khawar1,2,3, Ali Afzal1,4, Shuangshuang Dong1,5, Yue Si1,2, Haibo Sun1,2\u003Cbr>1Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu 225009, China;\u003Cbr>2Jiangsu Key Laboratory of Experimental & Translational Non-Coding RNA Research, Yangzhou, Jiangsu 225009, China;\u003Cbr>3Applied Molecular Biology and Biomedicine Lab, Department of Zoology, University of Narowal, Narowal, Punjab 51600, Pakistan;\u003Cbr>4Molecular Medicine and Cancer Therapeutics Lab, Department of Zoology, Faculty of Sciences and Technology, University of Central Punjab, Lahore, Punjab 54000, Pakistan; 5Department of Pathology, Northern Jiangsu People’s Hospital Affiliated to Yangzhou University/Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu 225000, China. |\n| Abstract\u003Cbr>Colorectal cancer (CRC), a major global health concern, necessitates innovative treatments. Chimeric antigen receptor (CAR) T cells have shown promises, yet they grapple with challenges. The spotlight pivots to the rising heroes: CAR natural killer (NK) cells, offering advantages such as higher safety profiles, cost-effectiveness, and efficacy against solid tumors. Nevertheless, the specific mechanisms underlying CAR NK cell trafficking and their interplay within the complex tumor microenvironment require further in-depth exploration. Herein, we provide insights into the design and engineering of CAR NK cells, antigen targets in CRC, and success in overcoming resistance mechanisms with an emphasis on the potential for clinical trials.\u003Cbr>Keywords: Chimeric antigen receptor; Natural killer cells; Colorectal cancer; Antigen targeting; Resistance mechanisms; Tumor microenvironment |\n\nIntroduction  \nImmunotherapy stands as a beacon of hope in the realm of cancer treatment, turning immune cells into formidable warriors against the relentless invader—the tumor. Central to this transformation are chimeric antigen receptor (CAR) therapies, engineering the immune system to seek and destroy cancer cells with unparalleled precision. Earlier, we showcased nanoengineering of better performing CAR T cells,[1] mitigating the barriers of tumor microenvironment (TME)[2] and precision in targeting hematological and solid cancers. [3] However, CAR T cells present certain demerits such as; limited T cell trafficking, immunosuppressive environment, and antigen escape. [4,5] In this context, the spotlight shifts to another unsung hero of the immune system—the natural killer (NK) cells which, hitherto, we explicitly have reviewed“From Natural Basis to Design for Kill,”[6] boosting the NK cells using neoantigens[7] and recent progress in preclinical and clinical settings. [8] Exclusively, CAR NK cells offer several merits as they do not cause cytokine release syndrome,[9] demonstrate higher safety profiles via multiple killing mechanisms,[10] are more cost effective when compared to CAR T cell therapy,[11] thereby readily  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code: | Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10.1097/CM9.0000000000003346 |\n\naccessible to patients and show promise in treating solid tumors such as glioblastoma,[12] an area where CART cell therapy has faced challenges. [13,14]  \nColorectal cancer (CRC) is the second and the fourth leading causes of cancer-related deaths worldwide and in China respectively, according to the GLOBOCAN,[15] owing to a 9.4% mortality rate and 1.9 million new cases reported in 2020 worldwide with relatively more incidence in older ages in males relative to females. [16] The very trend has recently been observed to be increasing ata faster rate among individuals of age \u003C50 years. [17] In 2020, the highest rates were documented in Australia/ New Zealand and European regions, whereas several African regions and Southern Asia reported the lowest rates. [18] The Asia-Pacific ","cbCaielzpujsz8Hm","https://ap.wps.com/l/cbCaielzpujsz8Hm","pdf",5847894,"English","# Introduction\n# CAR NK Cell Design and Engineering","[{\"question\":\"Why are CAR NK cells considered for colorectal cancer treatment?\",\"answer\":\"CAR NK cells are presented as alternatives to CAR T cells, offering advantages such as higher safety profiles, cost-effectiveness, and efficacy against solid tumors.\"},{\"question\":\"What challenges limit CAR T cell therapies in CRC?\",\"answer\":\"The text notes demerits including limited T cell trafficking, immunosuppressive tumor environments, and antigen escape.\"},{\"question\":\"What does the review focus on regarding CAR NK cells?\",\"answer\":\"It explains CAR NK cell design and engineering, identifies antigen targets in CRC, and discusses strategies to overcome resistance mechanisms with emphasis on preclinical progress and clinical trial potential.\"}]","Engineering and targeting potential of CAR NK cells in colorectal cancer - Review Article | PDF",1790012404,28]